Thromboelastometry as a Predictor of Thrombotic Complications During Pediatric Recipient Liver Transplantation
NCT ID: NCT03494595
Last Updated: 2018-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2018-12-31
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant
NCT02239991
Thrombin Generation in Liver Transplant Surgery
NCT04762550
Rotational Thromboelastometry (ROTEM) TRUE-NATEM Reference Value Validation in Liver Transplantation
NCT04282889
Viscoelastic Tests-Guided Therapy In Liver Transplantation
NCT03756948
Predictions of Bleeding During Liver Transplantation With Thromboelastometry
NCT02356068
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thromboelastometry offers rapid, comprehensive, and global clinical assessment of the patients' coagulation status, as demonstrated by several studies.
Little data exists in the use of thromboelastography (TEG) in pediatric liver transplantation. In 2011, Curiel et al implemented pre-transplant TEGs for patients listed for liver transplantation. The invistigators sought to examine if there were any correlations with preoperative hypercoagulable indices on the TEG and postoperative thrombotic complications.The invistigators have identified that a preoperative hypercoagulable TEG portends to thrombotic complications in pediatric liver transplant patients. Further studies are needed to explore perioperative management strategies for high risk patients to prevent the development of postoperative thrombotic complications based upon preoperative TEG studies. That's why the invistigators will study the perioperative thromboelastometry as a predictor of thrombotic complications during pediatric recipient liver transplantation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thrombosis
Patients who will develop thrombosis perioperatively
Pediatric Liver transplantation
Pediatric Liver transplantation
No thrombosis
Patients who will not develop thrombosis perioperatively
Pediatric Liver transplantation
Pediatric Liver transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pediatric Liver transplantation
Pediatric Liver transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is a recipient of a first liver allograft from living donors.
* Participant is a single-organ recipient (liver only).
* Participants' parent/guardian is capable of understanding the purposes and risks of the study and must sign an informed consent for the study.
Exclusion Criteria
* A history of liver transplantation.
* Multivisceral transplantation.
* Participants' parent/guardian refused to participate in the study.
3 Months
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Hamada Hamed
Assistant Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed HH Amin
Role: PRINCIPAL_INVESTIGATOR
Assistant Lecturer
Fatma AA Ahmed
Role: STUDY_CHAIR
Professor
Eman AE Ahmed
Role: STUDY_DIRECTOR
Assistant professor
Ghada MA Abdelhamid
Role: STUDY_DIRECTOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEG PLT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.